|
|
|
|
|
by dilyevsky
240 days ago
|
|
This is a series B company not an international pharmaceutical conglomerate. Perfectly reasonable for a CTO to participate in engineering work at this stage. I've experienced a few early companies where CTO just did meetings or that didn't have someone within the leadership team who dug into engineering at all and it wasn't pretty... |
|